glp 1 anti inflammatory Pro- and anti-inflammatory properties of GLP-1 receptor agonists. APC, GLP-1 drugs calm inflammation beyond

( PMID: 31823494 ) Collins MK, Choudhary S, Ho J, Bunimovich YL (2021) Bullous pemphigoid triggered by liraglutide

This process was clearly optimized for speed and volume, not necessarily patient safety

Nassif et al

This shift reflects a more mature interpretation of the evidence: the risk is not uniform across all GLP-1 users

The future oral GLP-1 receptor agonists, incretin dual agonists, triple agonists, and other new oral metabolic products will become popular only if they prove themselves capable of producing sustained results in obesity disease, type 2 diabetes, hypertension, dyslipidemia, cardiovascular risks, and metabolic syndromes through their effectiveness and safety

Patients can sign-up to receive automated email alerts for when a GLP-1 drug is reported in supply in their area, or when the status of a GLP-1 drug on the FDAs Drug Shortage List changes